Research Guides Glossary Longevity Atlas Intervention Atlas Blog About Support Contact Join the research →
A public, dated record of what the lab is doing — progress, learnings, and failures. Subscribe via RSS
2026
INFRA2026-08-08

Cryptocurrency support announced

The support page now offers a cryptocurrency option: Ethereum, Solana, Monero, Dogecoin, and USDC are being set up, with Bitcoin support to follow. Verified wallet addresses are being prepared — until they are live the options show as "Available soon," and no funds should be sent yet. Every contribution will be recorded in the annual transparency report, like every other form of support.

2026
MODEL2026-08-01

Causal aging model reaches v0.9

The causal graph now spans all twelve hallmarks of aging with explicit interaction edges and confidence scores. Next: systematic sensitivity analysis against independent datasets before we claim any edge is "validated."

2026
INFRA2026-07-22

Literature intelligence pipeline hits 1,200 papers

Our AI knowledge base has indexed and structured 1,200+ peer-reviewed papers on aging and longevity. Every claim we make in our own writing is traced to a source in this graph — we want to be able to show our work.

2026
EXPERIMENT2026-07-10

In-silico series: senescence clearance

Completed a 9,400-simulation series on clearance of senescent cells in a computational tissue model. Result: the "which cells to clear" question matters as much as "how." Write-up in progress; expected on the lab log next month.

2026
ETHICS2026-06-28

Research ethics framework drafted

We adopted a non-invasive-first ethics framework: no intervention study begins without independent review, no participant data leaves their control without explicit consent, and human studies are always the last step — not the first.

2026
DATA2026-06-15

Non-invasive biomarker catalog launched

Cataloged the evidence base for early-disease signals in wearables, routine blood panels, and standard imaging. This becomes the foundation for our observational study design — to be opened to waitlist members when ready.

2026
LEARNINGS2026-05-30

What we got wrong: biomarker hype check

We flagged five widely marketed "aging biomarkers" as insufficiently validated after tracing their evidence. None of them are used in our models. This is the kind of finding we will publish openly — the field needs fewer marketing claims.

Follow the work

Get the lab log in your inbox.

Monthly, honest updates on our research — including the results that didn't work.